59.10
Genedx Holdings Corp stock is traded at $59.10, with a volume of 429.11K.
It is down -6.75% in the last 24 hours and down -6.99% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$63.38
Open:
$63.65
24h Volume:
429.11K
Relative Volume:
0.34
Market Cap:
$1.75B
Revenue:
$442.68M
Net Income/Loss:
$-77.81M
P/E Ratio:
-22.15
EPS:
-2.6684
Net Cash Flow:
$-28.65M
1W Performance:
-6.90%
1M Performance:
-6.99%
6M Performance:
-41.69%
1Y Performance:
-27.44%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
59.10 | 1.75B | 442.68M | -77.81M | -28.65M | -2.6684 |
|
TMO
Thermo Fisher Scientific Inc
|
568.26 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
191.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
544.32 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
|
A
Agilent Technologies Inc
|
138.57 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
|
NTRA
Natera Inc
|
261.99 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Holdings Corp (WGS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WGS UPCOMING DEADLINE : The Gross Law Firm Alerts GeneDx Holdings Corp. Stockholders of Securities Class ActionContact the Firm - Supply Chain Digital
WGS LAWSUIT ALERT: Levi & Korsinsky Notifies GeneDx Holdings Corp. InvestorsLead Plaintiff Deadline August 3, 2026 - ACCESS Newswire
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp.WGS - PR Newswire
WGS 10-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: - GlobeNewswire
WGS 10-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline - GlobeNewswire Inc.
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline - PR Newswire
WGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Lost Money on GeneDx Holdings Corp. (WGS)? Join Class Action Suit Seeking RecoveryContact SueWallSt - TradingView
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Trading the Move, Not the Narrative: (WGS) Edition - Stock Traders Daily
Genedx Holdings Corp. (WGS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- August 3, 2026 Deadline - PR Newswire
WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - Charleston Gazette-Mail
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - Barchart.com
Robbins LLP Reminds WGS Investors of the Pending Class - GlobeNewswire
WGS Deadline Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - PR Newswire
GeneDx (WGS) Is Still Growing in Core Testing, but the Guidance Reset Changed the Story - AlphaStreet
GeneDx Holdings Corp. (WGS) warrants to be removed from Nasdaq listing - Stock Titan
INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors - GlobeNewswire
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Morningstar
GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of Expectations - Yahoo Finance
WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - marketscreener.com
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 3, 2026 Deadline - TMX Newsfile
WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, - GlobeNewswire
WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
WGS Shareholder Alert: GeneDx Holdings Corp. Securities - GlobeNewswire
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
The Bull Case For GeneDx Holdings (WGS) Could Change Following Fabric Genomics Impairment And Fraud SuitsLearn Why - simplywall.st
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings - GlobeNewswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class ActionContact Kessler Topaz Meltzer & Check, LLP - PR Newswire
WGS Stockholders Have Opportunity to Lead GeneDx Holdings Corp. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
WGS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GeneDx - GlobeNewswire
WGS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
WGS Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
GeneDx Holdings Corp. (WGS) Fell Following a Significant Cut in 2026 Guidance - Yahoo Finance
2026-07-17 | WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of GeneDx Holdings Corp. to Contact the Firm Today! | NDAQ:WGS | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming DeadlinesWGS - YCharts
GeneDx to report Q2 2026 financial results on August 3 - scanx.trade
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026 - Yahoo Finance
GeneDx Holdings Corp. (WGS) Faces Class Action Lawsuit Over Misl - GuruFocus
WGS DEADLINE: SueWallSt Reminds GeneDx Holdings Corp. Investors of Upcoming Securities Class Action Deadline - PR Newswire
GeneDx Holdings Corp. Class Action Reminder – Robbins LLP Encourages WGS Investors to Contact the Firm for Information About Their Rights - Business Wire
GENEDX HOLDINGS CORP. (WGS) SHAREHOLDER ALERT Bernstein - GlobeNewswire
WGS INVESTOR DEADLINE: GeneDx Holdings Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit- Hagens Berman - PR Newswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
2026-07-16 | WGS Stockholders Have Opportunity to Lead GeneDx Holdings Corp. Class Action LawsuitContact Bronstein, Gewirtz and Grossman, LLC Today! | NDAQ:WGS | Press Release - Stockhouse
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RUCH JOSHUA | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
33,299 |
| PFENNIGER RICHARD C JR | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
45,082 |
| Meister Keith A. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
23,705 |
| Leproust Emily M. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,852 |
| Casdin Eli | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,093 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
43,683 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Sale |
60.77 |
3,729 |
226,597 |
39,954 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
114,873 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Sale |
60.77 |
10,501 |
638,104 |
104,372 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 09 '26 |
Option Exercise |
0.00 |
2,462 |
0 |
37,752 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):